CagA protein seropositivity in a random sample of adult population and gastric cancer patients in Estonia

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 1, 1998, Pages 41-46

  Vorobjova, Tamara ^a   Nilsson, Ingrid ^b   Kull, Karl ^a   Maaroos, Heidi Ingrid ^a   Covacci, Antonello ^c   Wadström, Torkel ^b   Uibo, Raivo ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b LUND UNIVERSITY   (Sweden)

^c CHIRON VACCINES   (Italy)

Author keywords

CagA antibodies; Enzyme linked immunosorbent assay; Gastric cancer; Helicobacter pylori; Immunoblot

Indexed keywords

CAGA PROTEIN; CELL SURFACE PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; ANTIBODY TITER; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTONIA; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CANCER;

EID: 0031909343     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199801000-00008     Document Type: Article

References (32)

1. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-1131.
2. Asaka M, Kimura T, Kato M, Kudo M, Miki K, Ogoshi K, et al.: Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994; 73:2691-2694.
3. Gasbarrini G, Pretolani S, Bonvicini F, Gatto MRA, Tonelli E, Mégraud F, et al. A population based study of Helicobacter pylori infection in a European country: the San Marino Study. Relations with gastrointestinal diseases. Gut 1995; 36:838-843.
4. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol 1996; 31 (Suppl 214):31-33.
5. Rugge M, Cassaro M, Leandro G, Baffa R, Avellini C, Bufo P, et al. Helicobacter pylori in promotion of gastric carcinogenesis. Dig Dis Sci 1996; 41:950-955.
6. Held M, Nyrén O, Hansson LE, Wadström T, Adami HO, Engstrand L. Antibodies in gastric cancer patients to the cytotoxin associated antigen, CagA. Gut 1996, 39 (Suppl 2):A16.
7. Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58:603-610.
8. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration and gastric pathology. Lancet 1991; 338:332-335.
9. Talley NJ, Zinsmeister AR, Weaver A, Di Magno EP, Carpenter HA, Pérez-Pérez GI, et al.: Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991 ; 83:1734-1739.
10. Fox JG, Correa P, Taylor NS, Thompson N, Fontham E, Janney F, et al. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol 1992; 87:1554-1560.
11. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128 kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90:5791-5795.
12. Crabtree JE, Wyatt JI, Sobala GM, Miller G, Tompkins DS, Primrose JN, et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993; 34:1339-1343.
13. Blaser MJ, Pérez-Pérez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-2115.
14. Cover TL, Glupczynsky Y, Lage AP, Burette A, Tummuru MKR, Pérez-Pérez GJ, et al. Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol 1995; 33:1496-1500.
15. Kuipers EJ, Pérez-Pérez GI, Meuwissen SGM, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the CagA status. J Natl Cancer Inst 1995; 87:1777-1780.
16. Figura N. Helicobacter pylori exotoxins and gastroduodenal diseases associated with cytotoxic strain infection. Aliment Pharmacol Ther 1996; 10 (Suppl 1):79-96.
17. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa Gastroenterology 1996; 110:1744-1752.
18. Vorobjova T, Kisand K, Haukanömm A, Maaroos H-I, Wadström T, Uibo R. The prevalence of Helicobacter pylori antibodies in a population from southern Estonia. Eur J Gastroenterol Hepatol 1994; 6:529-533.
19. Maaroos H-I, Villako K, Sipponen P, Kekki M, Siurala M, Tammur R, et al. Helicobacter pylori and chronic gastritis in random population sample of Estonia. Arkh Pathol 1990; 10:9-11.
20. Blaser MJ, Chyon PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Cancer Res 1995; 55:562-565.
21. Kikuchi S, Wada O, Nakajima T, Nishi T, Kobayashi O, Konishi T, et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 1995; 75:2789-2793.
22. Thomson H: The cancer incidence in Estonia through European prism. Eesti Arst 1994; 5:355-359 (in Estonian).
23. Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965; 64:31-49.
24. Lelwala-Guruge J, Schalén C, Nilsson I, Ljungh Å, Tyszkiewicz T, Wikander M, et al. Detection of antibodies to Helicobacter pylori cell surface antigens. Scand J Infect Dis 1990; 22:457-465.
25. Xiang Z, Bugnoli M, Ponzetto A, Morgando A, Figura N, Covacci A, et al. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1993; 12:739-745.
26. Brown RA, Swanson Beck J. Statistics on microcomputers: a non-algebraic guide to the appropriate use of statistical packages in biomedical research and pathology laboratory practice. 6. Statistical methods for diagnostic tests. J Clin Pathol 1989; 42:225-230.
27. Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S, et al. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol 1995; 48:41-45.
28. Rucheton M, Stefas I, Lamaury I, Coste J, Reynes J, Lemaire JM, et al. Autoanticorps IgG contre un antigene cellulaire p72 croisant avec l'antigene (MLV) p15-gag: presence dans l'infection HIV1 precoce, dans l'infection HBV et le Gougerot-Sjögren primitif. C R Acad Sci Paris Ser III 1992; 533-538.
29. Crabtree JE, Webb P, Newell D, Covacci A, Forman D and the Eurogast Study Group. An epidemiological survey of CagA seropositivity in seventeen worldwide populations. Gut 1996; 39 (Suppl 2):A82.
30. Figura N, Vindigni C, Pinto E, Gennari C, Presenti L, Tosi P, et al. Gastric cancer, H. pylori (HP) infection, serum antibodies to CagA. Gut 1996; 39 (Suppl 2):A17.
31. Klaamas K, Held M, Wadström T, Lipping A, Kurtenkov O: IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer 1996; 67:1-5.
32. Nilsson I, Ljungh Å, Aleljung P, Wadström T. Immunoblot assay for serodiagnosis of Helicobacter pylori infections. J Clin Microbuiol 1997; 35:427-432.